Uploaded April 2026 | Updated September 2026, 2 weeks ago

---

Daniel Wang, M.D., Associate Professor of Internal Medicine in the Division of Hematology and Oncology and Co-Leader of the Sarcoma/Melanoma Disease Oriented Team at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, talks about tumor infiltrating lymphocyte (TIL) therapy available for eligible patients with advanced melanoma.